Aristo Bio-Tech and Lifescience (NSE:ARISTO) Construction In Progress: ₹1 Mil (As of Mar. 2025)


NSE:ARISTO Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
59 GF Score
Price ₹91.00
View Full Analysis

What is Aristo Bio-Tech and Lifescience Construction In Progress?

Aristo Bio-Tech and Lifescience NSE:ARISTO -4.91% 59 Construction In Progress is ₹1 Mil as of Mar. 2025. GuruFocus rates NSE:ARISTO with a GF Score™ of 59/100.

Aristo Bio-Tech and Lifescience's quarterly construction in progress declined from Mar. 2024 (₹1 Mil) to Sep. 2024 (₹0 Mil) but then increased from Sep. 2024 (₹0 Mil) to Mar. 2025 (₹1 Mil).

Aristo Bio-Tech and Lifescience's annual construction in progress declined from Mar. 2023 (₹11 Mil) to Mar. 2024 (₹1 Mil) and declined from Mar. 2024 (₹1 Mil) to Mar. 2025 (₹1 Mil).

Aristo Bio-Tech and Lifescience Construction In Progress Historical Data

* Premium members only.

The historical data trend for Aristo Bio-Tech and Lifescience's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience Construction In Progress Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Construction In Progress
Get a 7-Day Free Trial 0.00 0.98 10.97 1.21 0.91

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only 10.97 30.26 1.21 0.00 0.91
NSE:ARISTO
59GF Score
Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aristo Bio-Tech and Lifescience Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹1 Mil mean?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a Construction In Progress of ₹1 Mil as of Mar. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Aristo Bio-Tech and Lifescience and its competitors.
Is Aristo Bio-Tech and Lifescience's Construction In Progress too high?
Aristo Bio-Tech and Lifescience's current Construction In Progress is ₹1 Mil. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's Construction In Progress compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's Construction In Progress of ₹1 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for an Agriculture company?
A good Construction In Progress depends on the Agriculture industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Aristo Bio-Tech and Lifescience and its competitors. Aristo Bio-Tech and Lifescience's current Construction In Progress is ₹1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current Construction In Progress of ₹1 Mil. The current Construction In Progress is ₹1 Mil. Aristo Bio-Tech and Lifescience's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current Construction In Progress is ₹1 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aristo Bio-Tech and Lifescience Business Description

Address E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
59GF Score

Get the complete analysis for NSE:ARISTO

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹91.00
Price